170
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro

, , , , , , , , & show all
Pages 670-678 | Received 13 Jun 2011, Accepted 04 Aug 2011, Published online: 03 Apr 2012

References

  • Santus G, Baker RW. (2002). Osmotic drug delivery: A review of the patent literature. J Control Release, 35:1–21.
  • Verma RK, Krishna DM, Garg S. (2002). Formulation aspects in the development of osmotically controlled oral drug delivery systems. J Control Release, 79:7–27.
  • Makhija SN, Vavia PR. (2003). Controlled porosity osmotic pump-based controlled release systems of pseudoephedrine. I. Cellulose acetate as a semipermeable membrane. J Control Release, 89:5–18.
  • Gondaliya D, Pundarikakshudu K. (2003). The fabrication and evaluation of the formulation variables of a controlled-porosity osmotic drug delivery system with Diltiazem Hydrochloride. J Pharmaceutical Technology, 27:58–68.
  • Rajeshri W, Varma MM. (2010). Once a day osmotic drug delivery system for highly water soluble Pramipexole. J Chem Pharm Res, 2:136–146.
  • Zentner GM, Rork GS, Himmelstein KJ. (1985). The controlled porosity osmotic pump J Control. Release, 1:269–282.
  • Kanagale P, Lohray BB, Misra A, Davadra P, Kini R. (2007). Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin. AAPS PharmSciTech, 8:13–19.
  • Thombre AG, Cardinal JR, DeNoto AR, Herbigb SM, Smith KL. (1999). Asymmetric membrane capsules for osmotic drug delivery I-Development of a manufacturing process. J Control Release, 57:55–64.
  • Thombre AG, Cardinal JR, DeNoto AR, Gibbes DC. (1999). Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance. J Control Release, 57:65–73.
  • Philip AK. (2008). Osmotically regulated flow of flurbiprofen through in situ formed asymmetric membrane capsule. Curr Drug Deliv, 5:127–132.
  • Guarve K, Gupta GD. (2011). Formulation and evaluation of extended release asymmetric membrane capsules of atenolol. Curr Drug Deliv, 8:159–163.
  • Philip AK, Philip B. (2011). In Situ Phase-Transited Asymmetric Membrane Capsules: A Means for Achieving Delayed and Osmotic Release for pH Solubility-Dependant Drugs. PDA J Pharm Sci Technol, 65:32–41.
  • China Patent CN101301281. An osmotic pump controlled-release capsule shell and it’s preparation.
  • Theeuwes F. (1975). Elementary osmotic pump. J Pharm Sci, 64:1987–1991.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.